115 related articles for article (PubMed ID: 7834610)
1. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines.
Kondo Y; Kuo SM; Watkins SC; Lazo JS
Cancer Res; 1995 Feb; 55(3):474-7. PubMed ID: 7834610
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum.
Kondo Y; Kuo SM; Lazo JS
J Pharmacol Exp Ther; 1994 Sep; 270(3):1313-8. PubMed ID: 7932184
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin.
Webber MM; Rehman SM; James GT
Cancer Res; 1988 Aug; 48(16):4503-8. PubMed ID: 3396002
[TBL] [Abstract][Full Text] [Related]
4. Nucleophilic distribution of metallothionein in human tumor cells.
Woo ES; Kondo Y; Watkins SC; Hoyt DG; Lazo JS
Exp Cell Res; 1996 May; 224(2):365-71. PubMed ID: 8612713
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line.
Koropatnick J; Kloth DM; Kadhim S; Chin JL; Cherian MG
J Pharmacol Exp Ther; 1995 Dec; 275(3):1681-7. PubMed ID: 8531144
[TBL] [Abstract][Full Text] [Related]
6. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel.
Woo ES; Monks A; Watkins SC; Wang AS; Lazo JS
Cancer Chemother Pharmacol; 1997; 41(1):61-8. PubMed ID: 9443615
[TBL] [Abstract][Full Text] [Related]
7. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
Koropatnick J; Pearson J
Mol Pharmacol; 1993 Jul; 44(1):44-50. PubMed ID: 8341278
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.
Zhou XD; Sens MA; Garrett SH; Somji S; Park S; Gurel V; Sens DA
Toxicol Sci; 2006 Oct; 93(2):322-30. PubMed ID: 16854967
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor.
Leyshon-Sørland K; Mørkrid L; Rugstad HE
Cancer Res; 1993 Oct; 53(20):4874-80. PubMed ID: 8402675
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma.
Nakano M; Sogawa CA; Sogawa N; Mishima K; Yamachika E; Mizukawa N; Fukunaga J; Kawamoto T; Sawaki K; Sugahara T; Furuta H
Anticancer Res; 2003; 23(1A):299-303. PubMed ID: 12680227
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
13. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
Yang YY; Woo ES; Reese CE; Bahnson RR; Saijo N; Lazo JS
Mol Pharmacol; 1994 Mar; 45(3):453-60. PubMed ID: 7511778
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells.
Dutta R; Sens DA; Somji S; Sens MA; Garrett SH
Prostate; 2002 Jul; 52(2):89-97. PubMed ID: 12111700
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
[TBL] [Abstract][Full Text] [Related]
16. Induction of metallothionein is correlated with resistance to auranofin, a gold compound, in Chinese hamster ovary cells.
Monia BP; Butt TR; Mirabelli CK; Ecker DJ; Sternberg E; Crooke ST
Mol Pharmacol; 1987 Jan; 31(1):21-6. PubMed ID: 3807890
[TBL] [Abstract][Full Text] [Related]
17. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity.
Moffatt P; Plaa GL; Denizeau F
Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum.
Kuo SM; Kondo Y; DeFilippo JM; Ernstoff MS; Bahnson RR; Lazo JS
Toxicol Appl Pharmacol; 1994 Mar; 125(1):104-10. PubMed ID: 7510428
[TBL] [Abstract][Full Text] [Related]
20. [Metallothionein and its isoform genes expression in the human pancreatic cancer cell strains and their function].
Xie Y; Zhao YP; Chen G; Yuan CH; Li LJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):619-23. PubMed ID: 16274045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
